ETR/GIS (ETR/GIS)

Deutsche Börse Xetra: ETR/GIS · EUR

€143

+1.66 (+1.2%)· Recorded snapshot

Market cap	179.1B
Revenue (ttm)	26.7B
Net income (ttm)	-2.8B
EPS (ttm)	-€2.35
P/E (forward)	18.7x
Dividend	€2.80 (1.96%)
Volume	765
Beta	0.33

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 26.7B
Net income (ttm): -2.8B
EPS (ttm): -€2.35
P/E (forward): 18.7x
Market cap: 179.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.7

P25 13.5P50 19.1P75 28.3

Trailing P/En/a

P25 14.1P50 23.7P75 38.5

ROE-20.7

P25 -50.4P50 0.5P75 12

ROIC34.4

P25 -29.8P50 1.9P75 10.7

Benchmarks · 1M

All ETR/GIS indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-29
Employees	17,000
Employees change	-600
Employees growth	-3.41%
Enterprise value	EUR 198.2B
Exchange	Deutsche Börse Xetra
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1987
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US3755581036
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2013-01-28
Last stock split type	Forward
Market cap	EUR 179.1B
Next earnings date	2026-10-29
Price	EUR 143.28
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	etr/GIS
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	75.16x
Average P/E ratio (3Y)	133.64x
Average P/E ratio (5Y)	84.97x
Earnings yield	-1.64%
EV/EBIT	18.46x
EV/EBITDA	14.8x
EV/FCF	17.31x
EV/Sales	7.18x
FCF / EV yield	5.78%
FCF yield	6.4%
Forward P/E	18.73x
P/(FCF - SBC) ratio	16.81x
P/(OCF - SBC) ratio	16x
P/B ratio	17.22x
P/FCF ratio	15.63x
P/OCF ratio	14.92x
P/S ratio	6.64x
Price/EBITDA ratio	13.85x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	38.88%
EBITDA margin	47.94%
FCF margin	41.39%
Gross margin	79.6%
Operating margin	38.88%
Pretax margin	-6.42%
Profit margin	-10.64%
Profit per employee	EUR -166,822
Profitable years	19
Revenue per employee	EUR 1.6M
ROA	14.09%
ROA (5Y)	10.85%
ROCE	30.88%
ROE	-20.68%
ROE (5Y)	24.33%
ROIC	34.37%
ROIC (5Y)	21.93%
SBC / revenue	2.98%
Tax / revenue	4.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
FCF growth	38.15%
FCF growth (Q)	376.81%
FCF growth (QoQ)	41.45%
FCF growth 3Y	13.19%
FCF growth 5Y	8.85%
Gross profit growth	6.96%
Gross profit growth (Q)	11.52%
Gross profit growth 3Y	3.69%
Gross profit growth 5Y	1.75%
Net income growth years	1
OCF growth	37.33%
OCF growth (Q)	332.04%
OCF growth (QoQ)	40.45%
OCF growth 10Y	-2.84%
OCF growth 3Y	12.52%
OCF growth 5Y	8.31%
Operating income growth	7.34%
Operating income growth (Q)	-5.23%
Operating income growth 3Y	6.62%
Operating income growth 5Y	-1.1%
Revenue growth	5.52%
Revenue growth (Q)	10.18%
Revenue growth (QoQ)	12.11%
Revenue growth 10Y	-0.61%
Revenue growth 3Y	3.61%
Revenue growth 5Y	2.72%
Revenue growth quarters	5
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -533.1M
Depreciation and amortization	EUR 2.5B
EBIT	EUR 10.4B
EBITDA	EUR 12.8B
EPS	EUR -2.35
Financing cash flow	EUR -4.1B
Free cash flow	EUR 11.3B
Free cash flow minus SBC	EUR 10.5B
Gross profit	EUR 21.2B
Income taxes	EUR 1.1B
Investing cash flow	EUR -9.5B
Net borrowing	EUR 1.2B
Net cash flow	EUR -1.7B
Net income	EUR -2.8B
Operating cash flow minus SBC	EUR 11.1B
Operating income	EUR 10.4B
Revenue	EUR 26.7B
Stock-based compensation	EUR 795.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.05
Book value per share	EUR 8.34
Debt / EBITDA	1.78
Debt / equity	2.23
Debt / FCF	2.03
Goodwill	EUR 7.5B
Interest coverage	11.86
Long-term assets	EUR 30.7B
Long-term liabilities	EUR 23B
Net cash (debt)	EUR -18.7B
Net cash / market cap	-10.56%
Net debt / EBITDA	1.46
Net debt / equity	1.82
Net debt / FCF	1.65
Piotroski F-Score	5
Property, plant and equipment	EUR 5.2B
Shareholders' equity	EUR 10.3B
Tangible book value	EUR -9.2B
Tangible book value per share	EUR -7.42
Total assets	EUR 43.2B
Total cash	EUR 4.3B
Total debt	EUR 23B
Total liabilities	EUR 32.9B
WACC	5.72%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	EUR 12.5B
Current liabilities	EUR 9.9B
Current ratio	1.27
Inventory turnover	3.29
Net working capital	EUR 400M
Quick ratio	0.9
Working capital	EUR 2.6B
Working capital turnover	8.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.39%
Dividend growth	-0.53%
Dividend growth (10Y)	5.7%
Dividend growth (3Y)	0.31%
Dividend growth (5Y)	3.65%
Dividend growth years	0
Dividend payment date	2026-09-29
Dividend payment years	12
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.80
Dividend yield	1.96%
Ex-dividend date	2026-09-15
Last dividend	EUR 0.71
Shareholder yield	3.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	105.07%
10Y return CAGR	11.31%
10Y total return	191.98%
150-day SMA	EUR 119.98
1D price change	1.17%
1M price change	9.56%
1M total return	9.56%
1W price change	2.89%
1W total return	2.89%
1Y price change	38.6%
1Y return CAGR	42.04%
1Y total return	42.01%
20-day SMA	EUR 135.81
200-day SMA	EUR 120.74
3M price change	23.43%
3M total return	24.13%
3Y price change	96.49%
3Y return CAGR	29.26%
3Y total return	116.02%
50-day SMA	EUR 131.42
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 144.10
52-week high date	2026-10-28
52-week low	EUR 98.96
52-week low date	2025-10-31
5Y price change	147.21%
5Y return CAGR	24.19%
5Y total return	195.32%
6M price change	31.16%
6M total return	32.78%
All-time high	EUR 144.10
All-time high date	2026-10-28
All-time low	EUR 12.00
All-time low date	2007-01-24
Average true range (ATR)	EUR 2.81
Average volume	1.3K
Beta (5Y)	0.33
Change from 52-week high	-0.57%
Change from 52-week low	44.79%
Change from all-time high	-0.57%
Change from all-time low	1,094%
Change from open	0.77%
Day's gap	0.4%
Dollar volume	EUR 109,609
High price	EUR 144.10
Low price	EUR 141.76
Monthly RSI	73.33
Open price	EUR 142.18
Position in 52-week range	64.96%
Previous close	EUR 141.62
Price vs 150-day SMA	19.42%
Price vs 20-day SMA	5.5%
Price vs 200-day SMA	18.66%
Price vs 50-day SMA	9.02%
Relative volume	0.6
RSI	66.06
Sharpe ratio	1.46
Sharpe ratio (3Y)	0.9
Sharpe ratio (5Y)	0.82
Sortino ratio	2.52
Sortino ratio (3Y)	1.6
Sortino ratio (5Y)	1.5
Volume	765
Weekly RSI	71.24
YTD price change	34.81%
YTD total return	37.25%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.2B
Shares change (QoQ)	-0.88%
Shares change (YoY)	-1.39%
Shares held by insiders	0.09%
Shares held by institutions	90.91%
Short ratio	3.3 days

Deeper analysis on ETR/GIS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ETR/GIS report

Is a complete ETR/GIS research report available?

No complete published report is available for etr/GIS (ETR/GIS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ETR/GIS (ETR/GIS)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/GIS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/GIS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ETR/GIS

Frequently asked questions